Biotest AG
XETRA:BIO2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Biotest AG
XETRA:BIO2
|
DE |
|
Compeq Manufacturing Co Ltd
TWSE:2313
|
TW |
|
Palladium One Mining Inc
XTSX:PDM
|
CA |
|
T
|
Tomony Holdings Inc
TSE:8600
|
JP |
|
V2 Retail Ltd
NSE:V2RETAIL
|
IN |
|
B
|
Binex Co Ltd
KOSDAQ:053030
|
KR |
|
Carnegie Clean Energy Ltd
ASX:CCE
|
AU |
|
Jammu and Kashmir Bank Ltd
NSE:J&KBANK
|
IN |
|
K
|
Kawan Food Bhd
KLSE:BKAWAN
|
MY |
|
Tokyu Fudosan Holdings Corp
TSE:3289
|
JP |
|
B
|
Bridge SaaS Ltd
ASX:BGE
|
AU |
|
B
|
Biogen Inc
LSE:0R1B
|
US |
|
PetroFrontier Corp
XTSX:PFC
|
CA |
|
U
|
Universal Microelectronics Co Ltd
TWSE:2413
|
TW |
|
D
|
Digitree Group SA
WSE:DTR
|
PL |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BIO2's stock price target?
Not Available
BIO2 doesn't have any price targets made by Wall Street professionals.
What is Biotest AG's Revenue forecast?
Projected CAGR
-1%
For the last 8 years the
compound annual growth rate for
Biotest AG's revenue is
7%.
The projected
CAGR
for the next 1 year is
-1%.
What is Biotest AG's Operating Income forecast?
Projected CAGR
25%
For the last 8 years the
compound annual growth rate for
Biotest AG's operating income is
12%.
The projected
CAGR
for the next 1 year is
25%.
What is Biotest AG's Net Income forecast?
Projected CAGR
121%
The
compound annual growth rate
of Biotest AG's net income for the next 1 year is
121%.
